Non-small Nanoprobes Based on FDA-approval Formulation for NIR-II Imaging and Detection of Drug-induced Acute Kidney Injury

Jinxin Zhang,Xiao Chen,Jiqiang Liu,Tingfei Xie,Zhihui Huang,Xiaolu Sui,Pengfei Zhang,Jihong Chen
DOI: https://doi.org/10.1016/j.dyepig.2024.112598
IF: 5.122
2024-12-15
Dyes and Pigments
Abstract:Acute kidney injury (AKI) leads to an increase in glomerular filtration barrier porosity and interstitial space, resulting in a rapid decline in renal function and posing a significant threat to the health of hospitalized patients. In this study, indocyanine green (ICG)-doped nanoparticles (nanoICG) were developed and, based on FDA-approval polymeric formulations and found these non-small nanoparticles with ∼300 nm exhibited a longer residence time in the kidneys of mice suffering from drug-induced kidney injury. In contrast to previous attempts to develop renal-clearable molecular probes or ultrasmall nanoparticles (1–10 nm), this work provided new inspiration for the development of a nanoscale delivery system for kidney injury treatment helping to prevent the progression of the disease.
engineering, chemical,chemistry, applied,materials science, textiles
What problem does this paper attempt to address?